Nanomaterials for Cancer Diagnostics and Therapeutics
Nanomaterials for Cancer Diagnostics and Therapeutics
批准号:
7292749
负责人:
CHAD A. MIRKIN
金额:
$377.81万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-09-30 至 2010-08-31
关键词:
AddressAreaCancer CenterCancer DetectionCancer DiagnosticsCellular biologyChadChicagoClinicClinicalClinical TrialsCollaborationsComprehensive Cancer CenterConceptionsDetectionDevelopmentDiagnosisEngineeringExtramural ActivitiesFacultyFundingGoalsGrantIllinoisImageIndividualInstitutesInterdisciplinary StudyInternationalJointsLaboratoriesLegal patentMalignant NeoplasmsMedicalNanotechnologyNumbersPathway interactionsPatientsPersonal SatisfactionPopulation SciencesPrincipal InvestigatorPublicationsRangeRecording of previous eventsResearchResearch PersonnelResearch Project GrantsScientistScreening for cancerSouth KoreaTechnologyTestingTherapeuticUniversitiesanticancer researchbasecancer celldesignin vivoinnovationmembermolecular imagingmultidisciplinarynanonanodevicenanomaterialsnanoscalenanotoolnovelprogramssynergism
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The potential impact of nanotechnology is well recognized, and significant advances in the medical field are expected to be realized first. It is possible that nanotechnology will be the fundamental driver of advances in oncology and cancer research leading to near-term benefits for patients, and yet formidable challenges must be met. Northwestern University proposes to meet these challenges through the establishment of a Nanomaterials for Cancer Diagnostics and Therapeutics Center for Cancer Nanotechnology Excellence (CCNE). To be led by the Principal Investigator, Chad A. Mirkin, the proposed CCNE represents the development of a strong integrated partnership between the NU Robert H. Lurie Comprehensive Cancer Center (RHLCCC), and the NU International Institute for Nanotechnology (IIN). The RHLCCC is an NCI designated, comprehensive, University-based, matrix cancer center conducting a broad range of multidisciplinary basic, clinical, and population science research with over $116 million dollars in annual extramural funding. The NU International Institute for Nanotechnology (IIN) is an umbrella organization which unites all of the nanotechnology research and educational programs at NU, and encourages and supports collaborations with the Center for Nanoscale Materials (CNM) at Argonne National Laboratory. Investigators in the NU IIN currently are supported by more than $130 million in extramural funding. Building upon the significant advances in cancer research and in nanotechnology - particularly in the detection arena - obtained at NU, and operating within the framework of a single university will permit this CCNE to optimize the intensive level of integration and collaboration required to create an accelerated pathway-from conception to clinical trial-for development of nanomaterials and nanodevices to overcome cancer. Other academic collaborators include the University of Chicago, the University of Illinois/Urbana-Champaign, and Yonsei University, South Korea.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Spherical Nucleic Acid nano-architectures as first-in-class cGAS agonists for the immunotherapeutic treatment of Glioblastoma.
-
批准号:10539146
-
项目类别:
-
资助金额:$44.35万
-
财政年份:2022
-
负责人:CHAD A. MIRKIN
-
依托单位:
Spherical Nucleic Acid nano-architectures as first-in-class cGAS agonists for the immunotherapeutic treatment of Glioblastoma.
-
批准号:10709540
-
项目类别:
-
资助金额:$42.56万
-
财政年份:2022
-
负责人:CHAD A. MIRKIN
-
依托单位:
Innovative Research for Cancer Nanotechnology (IRCN) for Enhancing Melanoma-specific Immune Responses by the Rational Design of Spherical Nucleic Acids
-
批准号:10402178
-
项目类别:
-
资助金额:$52.19万
-
财政年份:2022
-
负责人:CHAD A. MIRKIN
-
依托单位:
Innovative Research for Cancer Nanotechnology (IRCN) for Enhancing Melanoma-specific Immune Responses by the Rational Design of Spherical Nucleic Acids
-
批准号:10591545
-
项目类别:
-
资助金额:$50.89万
-
财政年份:2022
-
负责人:CHAD A. MIRKIN
-
依托单位:
Systemic RNA interference to reactivate p53 tumor suppression
-
批准号:10091404
-
项目类别:
-
资助金额:$35.29万
-
财政年份:2017
-
负责人:CHAD A. MIRKIN
-
依托单位:
Nucleic Acid-Based Nanoconstructs for the Treatment of Cancer
-
批准号:8962037
-
项目类别:
-
资助金额:$233.23万
-
财政年份:2015
-
负责人:CHAD A. MIRKIN
-
依托单位:
Topical Delivery of siRNA Nanconjugates: Suppressing Epidermal Hyperplasia
-
批准号:8433345
-
项目类别:
-
资助金额:$32.51万
-
财政年份:2012
-
负责人:CHAD A. MIRKIN
-
依托单位:
siRNA-gold nanoparticle mediated ganglioside depletion for diabetic wound healing
-
批准号:8513708
-
项目类别:
-
资助金额:$5.85万
-
财政年份:2012
-
负责人:CHAD A. MIRKIN
-
依托单位:
Topical Delivery of siRNA Nanconjugates: Suppressing Epidermal Hyperplasia
-
批准号:8237282
-
项目类别:
-
资助金额:$34.22万
-
财政年份:2012
-
负责人:CHAD A. MIRKIN
-
依托单位:
Topical Delivery of siRNA Nanconjugates: Suppressing Epidermal Hyperplasia
-
批准号:8632993
-
项目类别:
-
资助金额:$33.53万
-
财政年份:2012
-
负责人:CHAD A. MIRKIN
-
依托单位:
siRNA-gold nanoparticle mediated ganglioside depletion for diabetic wound healing
-
批准号:8435386
-
项目类别:
-
资助金额:$19.04万
-
财政年份:2012
-
负责人:CHAD A. MIRKIN
-
依托单位:
Administrative Core
-
批准号:8545729
-
项目类别:
-
资助金额:$5.77万
-
财政年份:2012
-
负责人:CHAD A. MIRKIN
-
依托单位:
siRNA-gold nanoparticle mediated ganglioside depletion for diabetic wound healing
-
批准号:8285048
-
项目类别:
-
资助金额:$20.58万
-
财政年份:2012
-
负责人:CHAD A. MIRKIN
-
依托单位:
Nanomaterials for Cancer Diagnostics and Therapeutics
-
批准号:8313166
-
项目类别:
-
资助金额:$5.77万
-
财政年份:2010
-
负责人:CHAD A. MIRKIN
-
依托单位:
Administrative Core
-
批准号:7983877
-
项目类别:
-
资助金额:$23.16万
-
财政年份:2010
-
负责人:CHAD A. MIRKIN
-
依托单位:
Nanomaterials for Cancer Diagnostics and Therapeutics
-
批准号:7975900
-
项目类别:
-
资助金额:$240.0万
-
财政年份:2010
-
负责人:CHAD A. MIRKIN
-
依托单位:
Nanomaterials for Cancer Diagnostics and Therapeutics
-
批准号:8708292
-
项目类别:
-
资助金额:$5.4万
-
财政年份:2010
-
负责人:CHAD A. MIRKIN
-
依托单位:
Nanomaterials for Cancer Diagnostics and Therapeutics
-
批准号:8545722
-
项目类别:
-
资助金额:$213.07万
-
财政年份:2010
-
负责人:CHAD A. MIRKIN
-
依托单位:
Nanomaterials for Cancer Diagnostics and Therapeutics
-
批准号:8396702
-
项目类别:
-
资助金额:$5.77万
-
财政年份:2010
-
负责人:CHAD A. MIRKIN
-
依托单位:
Nanomaterials for Cancer Diagnostics and Therapeutics
-
批准号:8145721
-
项目类别:
-
资助金额:$232.96万
-
财政年份:2010
-
负责人:CHAD A. MIRKIN
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: